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Vitamin A is required for normal development, defence of the immune system and for 
maintaining good eye health in infants and children. Vitamin A deficiency is a major public 
health problem globally and in South Africa. Routine supplementation with high-dose Vitamin A 
has been a strategy employed to reduce the burden of Vitamin A deficiency in children aged 
from six to 59 months. Coverage of vitamin A supplementation (VAS) however remains low in 
older children in South Africa particularly in Amajuba Health District. 
Objectives:  
The objectives of this study were to measure VAS coverage and factors associated with poor 
VAS uptake in this District. 
Methods 
An analytic cross sectional study design was used. A two-stage cluster-sample method was used 
to select the participants. The study population involved mothers and caregivers of children aged 
12 to 59 months residing in Madadeni, a township in the District. The study sample of 198 
participants was obtained from 33 randomly selected clusters within each of which 6 households 
were approached. Data was collected using a field-worker administered structured questionnaire. 
The study received ethical approval (BE 368/15) and was conducted with participant’s consent.  
Results 
The coverage of VAS amongst these children was 57% (95% CI: 49 - 63). Younger children (18 
to 23 months) had better (Prevalence Ratio (PR) 1.2 (95% CI: 0.8 - 1.6) coverage than older 
children. Children who were up to date with VAS coverage were significantly more likely to 
have received a measles vaccine (p<0.01). A significant association was found between VAS 
status of children and caregivers being able to identify the blue capsules as the 6 to 11-month 
dose and the red capsules as the 12 to 59-month Vitamin dose capsule. There was a non-
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significant but positive association of a child having received VAS and higher level of education 
of the caregivers, shorter distance from health facilities, living in an urban area and having 
received information about VAS from a health worker 
Conclusion and Recommendations   
Amajuba Health District had a VAS coverage of 57%, which is below the national target of 65%. 
The low levels of knowledge about Vitamin A among caregivers is a concern, despite knowledge 
being weakly associated with VAS uptake in children. Health workers need to provide better 
education for caregivers about Vitamin A. Focus should also be placed on accessing older 
children as they are more likely miss VAS doses. (385 words) 
 
Dissertation Format:  
This dissertation is presented in the Journal Article Manuscript Format approved by the 
University of KwaZulu-Natal. In place of presenting a ‘Results’ chapter, a Journal Article 
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1 CHAPTER I: INTRODUCTION 
1.1 BACKGROUND 
In this introductory chapter, a background on the state of vitamin A deficiency globally and in South 
Africa is presented along with the state of vitamin A supplementation in South Africa and more 
specifically in Amajuba Health District. This chapter presents a picture of what is known so far about 
Vitamin A supplementation coverage and what still needs to be known. This then leads us to the 
purpose and importance of the current study; a statement of a problem and how this study will solve 
this problem. 
1.1.1 What is known so far?  
Vitamin A is an important nutrient required for normal growth and development of infants and 
children, for integrity of the immune system and for good eye health. (1) Vitamin A is a fat-soluble 
substance. Vitamin A is made up of the building blocks retinol, retinaldehyde and retinoic acid. There 
are two forms of vitamin A, preformed (animal sources) and provitamin A (plant sources). Children 
normally get vitamin A from food sources such as breastmilk, green leafy vegetables, yellow and 
orange fruits and vegetables, eggs, cheese and liver. Signs of vitamin A deficiency include 
xerophthalmia, anaemia and growth retardation. Vitamin A deficiency is most common in young 
children, particularly pre-school aged children. Young children are more susceptible to the deficiency 
because they are more prone to dietary deprivation either through poor breastfeeding or weaning 
practices. Young children are also more susceptible to diarrhoea, common infections and malnutrition 
which are all risk factors for VAD(2). Vitamin A deficiency (VAD) is a major public health problem, 
worldwide, but also in South Africa with many children being affected. (3) Vitamin A supplementation 
(VAS) is one of strategies employed by the South African Department of Health to reduce VAD, thus 
improving child health and moving towards achieving sustainable development goal 3 which is about 
ensuring healthy lives and promoting well-being for all ages. (4, 5) Coverage of routine VAS tends to be 
higher among the younger age groups (6 to 11 months) in comparison to the older age groups (12 to 60 
months)(6), mainly due to children in the older age group accessing health services less often.(7)  The 
current national coverage of VAS at 52% is below the national target of 65%. (7)  Amajuba Health 
District is also one of districts which is underperforming and is below the national target of 65% as 
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well as the national average of 52%.(7) Current information on national, provincial and district coverage 
of VAS is based on administrative measures of coverage; that is; it is based on tally sheet data collected 
at points of service where vaccines and VAS is administered. (8) Other strategies to improve VAS status 
include the food-based interventions through the promotion of dietary diversification which can target 
infants, young children and lactating mothers. This involves encouraging the consumption of vitamin A 
rich foods and establishing food gardens. Food fortification is also a strategy to improve VAS status.(9)   
Recommendations on the use of VAS in children aged 6 to 59 months arose from two WHO technical 
consultations to review scientific evidence for the reduction of child morbidity and mortality. This 
consultative group consisted of 46 experts including ministries of health, Food and Nutrition Research 
Institute. VAS guidelines were developed based on two Cochrane systematic reviews looking at the 
effect and safety of VAS in children.(2)  
1.1.2 What needs to be known? 
As coverage is routinely measured at Health District level by administrative means, community-based 
measures of coverage need to be explored, which will allow us to compare VAS coverage estimates 
determined using both measures. The knowledge, attitudes and practices of caregivers of children from 
different age groups about VAD and VAS also need to be known so that we may be able to determine 
whether these are associated with children either receiving or not receiving vitamin A. 
1.1.3 What is the importance of this study? 
Investigating the problem of low VAS coverage is important because low coverage can lead to 
increased prevalence of vitamin A deficiency in children; leading to increased child morbidity and 
mortality. (1)Understanding why some children have not had VAS could help influence policy and 
practice of this component of the Expanded Programme on Immunization. The main importance of this 
study is that it will be a step towards improving vitamin A status and coverage in the study area. 
1.1.4 How the study will solve the problem? 
The study investigated VAS coverage and possible causes of low coverage in Amajuba Health District 
by comparing characteristics of caregivers of children who are up to date in receiving Vitamin A doses 
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with children who are not. Through identifying factors which possibly contribute to not receiving 
Vitamin A, it allows for better planning of interventions and for programme enhancement .(1) 
1.2 STATEMENT OF THE PROBLEM 
The problem at hand is the low coverage of Vitamin A supplementation in children aged from 12 to 59 
months despite the health service being freely available at all primary health care facilities in South 
Africa. Coverage is stated as ‘being low’ based on Amajuba Health district coverage being below the 
national and provincial targets. 
1.2.1 Research Hypothesis 
The null hypothesis of this study is that there is no difference between the demographic and other 
characteristics of mothers and caregivers of children who are up to date in receiving VAS and those of 
children who are found not to be up to date in receiving VAS. 
1.2.2 Research Questions 
This study aims to answer the following research questions: 
• What is the coverage of VAS among children aged 12 to 59 months in Amajuba Health District 
in 2016?  
• Is there an association between VAS status in children aged 12 to 59 months and caregiver and 
child characteristics such as age, race, area of household, education level, income level, access 
to media and information, knowledge on Vitamin A, immunization status?  
1.3 PURPOSE OF THE RESEARCH  
The purpose of this research is to find possible ways to improve vitamin A status and coverage   in 
Amajuba Health District and to investigate the reasons for low uptake of Vitamin A supplementation in 
children aged 12 to 59 months in 2016, in order to inform policy and practice. 
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1.4 SPECIFIC OBJECTIVES  
The specific objectives of this research were:  
• To measure coverage of Vitamin A supplementation in Amajuba Health District; and  
• To compare the characteristics of children who are up to date with VAS with those who are not 
up to date with receiving VAS and identify associations.  
 
1.5 OPERATIONAL DEFINITIONS USED IN THE STUDY 
Children who are up to date in receiving VAS in this study refers to children who are found to have 
received a dose of VAS within the previous six months and children who are not up to date are 
defined as those children who have not received a dose of VAS within the previous six months. 
Vitamin A status is also used to refer to this concept in this report. 
Routine Vitamin A supplementation coverage: Proportion of children aged 12 to 59 months 
receiving at least one dose of Vitamin A capsule (100 000IU if 0 to 11 months) or 200 000IU (if 
between 12 to 60 months) in the past six months. 
Household: A household is a group of persons who live together and provide themselves jointly with 
food and/or other essentials for living, or a single person who lives alone.(10) 
Urban: A classification based on dominant settlement type and land use. Cities, towns, townships, 
suburbs, etc., are typical urban settlements. Enumeration areas comprising informal settlements, 
hostels, institutions, industrial and recreational areas, and smallholdings within or adjacent to any 
formal urban settlement are classified as urban. A formal urban settlement is structured and organised. 
Land parcels (plots or erven) make up a formal and permanent structure. A local council or district 
council controls development in these areas. Services such as water, electricity and refuse removal are 




Rural: Any area that is not classified urban. Rural areas are subdivided into tribal areas and 
commercial farms.   
FORMAT OF THIS DISSERTATION 
The following chapters are included in this report, which is presented in the Journal Article Manuscript 
format  
Chapter 1:  Includes an introduction to the report, laying out the research topic at hand, a problem 
statement is presented as well as the purpose and objectives of the study. 
Chapter 2:  Includes a review of the literature focusing on vitamin A supplementation, vitamin A 
deficiency, vitamin A supplementation coverage nationally, provincially and at district level, it also 
explores methods previously used to measure VAS coverage as well as barriers to VAS. 
Chapter 3:  Journal article manuscript 
Chapter 4: Additional findings, discussion and limitations, presenting a synthesis of findings and 
expanding on limitations in the study.  
1.6 SUMMARY OF CHAPTER 
This chapter provided a statement of the problem, which was low VAS coverage in the 12 to 59 month 
age group. The chapter also presented what is currently known about VAS, which included the health 
benefits of vitamin A, the status of VAS coverage in South Africa and in Amajuba Health District. The 
chapter also outlined what still needs to be known, namely community-based estimates of VAS 
coverage and caregiver knowledge, attitudes and practices.  This chapter provided a background upon 
which this research is based. 
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2 CHAPTER II: LITERATURE REVIEW 
2.1 INTRODUCTION 
In this literature review, the burden of VAD is reviewed both globally and in South Africa, along with 
its consequences. The various strategies which are implemented in order to reduce VAD are visited in 
this review. Focus is then drawn on one of these strategies; that being VAS; which is the focus of this 
study. More specifically, the vitamin A supplementation program of the South African Department of 
Health is defined and reviewed. Furthermore, various methods of measuring coverage of VAS are 
explored, including administrative-based methods and population-based surveys. In addition, the two-
stage cluster sampling method in measuring coverage is also explored. Finally, the literature review 
looks at barriers to VAS programs as reported by various studies which have also explored VAS.  
2.2 SCOPE OF LITERATURE REVIEW 
The literature for this research was acquired through various sources including electronic journals, web 
references and government documents. Search terms included words such as: “vitamin A deficiency, 
vitamin A supplementation in children, vitamin A supplementation coverage in South Africa, in 
Amajuba Health District, causes of low vitamin A supplementation coverage, methods for measuring 
immunisation coverage” 
2.3 LITERATURE REVIEWED 
2.3.1 Vitamin A deficiency  
Vitamin A deficiency, according to the World Health Organization (WHO), is globally a significant 
public health issue in 96 countries. (3) A reported 190 million (95% Confidence Interval (CI): 170 - 
202) or 33% of preschool children are estimated to have VAD (serum retinol <20µg/Dl).(11); which is 
particularly a significant public health issue in many middle-income countries, including South Africa. 
(4) The South African National Food Consumption Survey reported in 2005, that the prevalence of 
VAD in children aged 1 to 9 years was 63.6%, based on a survey sample of 3120 children. (4) The 
South African National Health and Nutrition Examination Survey (SANHANES) more recently in 
2013 reported that the national VAD prevalence for South Africa was (43.6% 95% CI: 36 - 51) for 
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children under the age of five years. (12) Data from the South African Vitamin A Consultative Group 
(SAVACG) reported a VAD prevalence of 34% in the year 2000 for children under 4 years.(13) The 
SANHANES and SAVACG studies assessed VAD within different but close age groups and looking at 
the data reported between 2000 and 2013, it appears there has hardly been a reduction in VAD 
prevalence in SA.VAD prevalence in SA is still a significant public health issue because according to 
the WHO, a country is considered to have a significant public health problem of VAD if the prevalence 
is higher than 20%. (12)  This can have dire consequences on the health of the individual as discussed in 
the next section. 
2.3.2 Consequences of Vitamin A deficiency 
Vitamin A is a crucial nutrient for normal growth and development, for a strengthened immune system 
and for eye health.(14) Vitamin A deficiency is the consequence of diets which are insufficient in 
vitamin A, leading to low body stores of the micronutrient. This deficiency can lead to compromised 
physiological functions such as tissue growth and resistance to infections.(15) Thus, children with VAD 
have increased vulnerability to childhood illnesses and infections including measles and diarrhoeal 
diseases, and are at an increased risk of developing nyctalopia (night blindness).(3)  More severe VAD 
is a risk for xerophthalmia and blindness. (14) The WHO estimates VAD contributes to 6% of under-five 
child deaths in Africa (16), while VAS can lead to a 23% reduction in all-cause mortality among 
children.(4)  Strategies thus need to be in place to reduce the burden of VAD. 
2.3.3 Strategies to reduce the burden of 
Vitamin A deficiency 
There are a number of approaches which are implemented in different countries to reduce the burden of 
VAD.(3) Such approaches include the promotion of breastfeeding, food fortification, improving dietary 
behaviour as well as VAS.(3) Of these interventions, routine supplementation with high dose vitamin A 
capsules has been shown to be the highest-impact intervention and is cost-effective.(3) Vitamin A 
supplementation for children aged 6 to 59 months can contribute to reducing child morbidity and 
mortality, thus moving towards achieving moving towards achieving sustainable development goal 
number 3 which is about ensuring healthy lives and promoting well-being for all ages, in countries 
where VAD is a significant public health concern.(5, 17)  
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2.3.4 Vitamin A supplementation 
programme in South Africa 
Measuring Vitamin A coverage 
VAS is indeed one of strategies which have been adopted by South African Department of Health with 
the aim of preventing VAD.(4) The VAS program was first introduced in South Africa in 2001.(4) In 
South Africa, vitamin A is given routinely to children aged 6 to 59 months, every 6 months, the first 
dose given at 6 months of age.(3) A dose of 100 000IU (blue capsule) is given to children aged 6 to 11 
months and a dose of 200 000IU (red capsule) is given to children aged 12 to 59 months.(3) The VAS 
program in South Africa is primarily delivered through health facilities together with the EPI and IMCI 
programmes.(4)  
The indicator for VAS coverage as defined by UNICEF is the percentage of children aged six to 59 
months who have received two age appropriate VAS capsules at six month intervals in the past 12 
months.(11)  The denominator is multiplied by 2 as children routinely should receive 2 doses annually.(4) 
The integration of the VAS program with other child health services such as EPI has been found to be 
very successful in achieving good coverage in children under the age of one year but has been less 
successful in achieving the same coverage among the 12 to 59 month age group.(18) This can mainly be 
attributed to reduced clinic attendance of children after 18 months of age where the immunization 
schedule stops until children reach the age of five years.(18) As a strategy to address this issue, ward 
based outreach teams have been deployed to administer vitamin A supplementation at household and 
community level.(7) Despite this effort, South Africa is among many countries which face challenges 
with regard to achieving good Vitamin A coverage among the 12 to 59 month age group.(19)  
The United Nations Children’s Fund (UNICEF) reported global coverage of VAS in 2011 was 75% for 
children receiving at least two VAS doses annually. (20)Although national coverage has been increasing 
steadily over the past decade from 12.8% in 2004/05 to 44% in 2013/14, which was still below the then 
national target of 60% in 2013/14.(19)  National VAS coverage further improved to 52% in 2014/2015, 
which was still below the new national target of 55% for 2014/2015.(7)  KwaZulu-Natal has improved 
from a VAS coverage of 49% in 2013/2014 to 55% in 2014/2015.(7) Amajuba Health District which is 
the setting of the proposed study is one of districts in South Africa with the lowest Vitamin A 12 to 59 
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months coverage which was a low 35% in 2013/14  and improved to 50% in 2014/2015.(7, 19)  Coverage 
for 2015/16 in Amajuba District is 54% and is still below the national target of 65%.1 
  
2.3.5 Barriers to achieving good Vitamin A 
supplementation coverage 
A number of studies have been conducted with the aim of identifying possible challenges and barriers 
to achieving optimal Vitamin A coverage. One such study was a cross sectional study conducted in 
Nepal which sought to identify demographic and other differences between children aged 12 to 59 
months who received vitamin A and those who did not receive vitamin A.(1) This was a countrywide 
survey involving a sample of 4013 children.(1) This particular study was based on data already collected 
during the 2011 Nepal Demographic and Health Surveys and Vitamin A was not the primary 
information being collected.(1) This study reported a strong association between children not receiving a 
dose of vitamin A in the previous 6 months and lower levels of education in mothers as well as living 
in a rural area.(1) For instance children with mothers who had less than a year of education had higher 
odds ratios of not receiving vitamin A (OR 1.7; 95% CI: 1.0 -2.7) compared to children who had 
mothers with higher levels of education.(1) Odds of not receiving vitamin A also decreased with 
increasing levels of education.(1) The odds ratio of children not receiving vitamin A was higher in rural 
areas (OR 1.7; 95% CI: 1.2-2.6) than in urban areas.(1) 
Slightly differing findings were reported in a similar cross sectional study conducted in Tanzania in 
2013.(21) This study had a sample of 1203 children aged 6 to 59 months.(21) In this study it was reported 
that children living in rural areas had significantly higher odds ratio (OR 3.3; 95% CI: 1.5-7.0)of 
receiving vitamin A than those children living in urban areas.(21) No significant relation was found 
between maternal education and receipt of vitamin A by children in this study.(21) In addition, this study 
                                                 
1 Data from district health information system 2015/16 
10 
 
reported that children with more siblings had higher odds of receiving vitamin A than children with no 
siblings. (21)  
Another cross sectional study was conducted in India in 2013 , which was based on existing data from 
India’s National Family Health Survey conducted between 2005 and 2006.(14) This was a cross 
sectional survey involving a sample of 20 802 children aged between 12 and 35 months.(14)This study 
reported increased likelihood of vitamin A receipt in children with mothers who had higher levels of 
education (OR 2.4; 95% CI: 2.0-2.8), higher income and socio-economic status.(14) The study found 
higher levels of vitamin A receipt in rural than urban areas in an adjusted logistic regression model (OR 
1.2; 95% CI: 1.1-1.3) (14). It was also found that younger children (12 to 23 months) were more likely 
to receive vitamin A than older children (24 to 35 months).(14) A positive association between children 
receiving vitamin A and a higher level (more than 10 years) of maternal education (Prevalence Ratio 
1.1, 95% CI 1.0-1.1) was also found in a 2010 cross sectional study.(22) The study was based on a 
national survey conducted in Bangladesh in 2004 on a sample of 3745 children aged 18 to 59 months. 
On a different perspective, a South African study conducted in 2011 investigated the opinions and 
knowledge of mothers of small children on the VAS program at primary health clinics as well as the 
opinions of staff members at these clinics.(23) The study was conducted in the Western Cape Province 
of South Africa; in the rural Overberg District Municipality and the urban Cape Town Metropolitan 
Municipality.(23) A total sample of 176 mothers of children below the age of five years were 
interviewed.(23) In this study, it was found that a higher proportion of children in living in rural areas 
had received vitamin A than children living in urban areas.(23) It was also reported that a relatively low 
proportion of mothers who were part of the study had knowledge of why their children were receiving 
vitamin A and an even smaller proportion had been given written information on vitamin A.(23) Missed 
opportunities for vitamin A supplementation were also identified at primary health clinics in this study. 
(23) Challenges which were brought up by staff members who were interviewed in the study included 
shortage of vitamin A Capsules and insufficient staff training on the Vitamin A program.(23) 
Similar findings were reported by another South African study with a similar design. In this study 
conducted in 2007 by in the Boland area of the Western Cape; missed opportunities for VAS were also 
reported.(24) Low levels of maternal knowledge on vitamin A were also reported by this study. In this 
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study, unavailability of vitamin A capsules at facilities was reported as a barrier to implementation but 
staff training was not reported as a barrier.(24) Both of the latter studies may have some limitations of 
having small sample sizes as well as being prone to selection bias due to only looking at those children 
who attended primary health clinics. However, they do provide some valid suggestions of possible 
challenges which may contribute to lower than optimal vitamin A coverage. 
2.3.6 Two-stage cluster sampling  
The common way of estimating VAS coverage is through the administrative process of reviewing tally 
sheets at points of administration which generate data on supplementation.(8)   The advantage of this 
method is that it is simple and time-efficient. This method has shortcomings as it may be characterized 
by human error in recording or incorrect calculations.(8) The quality of such data is often influenced by 
the quality of a country’s health information system.(18) 
Population-based surveys provide another method of measuring vitamin A supplementation coverage. 
(18) This is when data on VAS coverage is collected from country-wide surveys, for example, from 
demographic and health surveys.(18) These surveys can be useful in verifying tally sheet coverage 
estimates but have a limitation of being prone to recall bias.(18)   
Another method of measuring coverage is through post-event coverage surveys.(8) These are conducted 
at household level with caregivers of children aged 6 to 59 months.(8) This method may be used to 
estimate VAS coverage, verifying it against tally sheet data, and can also be used as an opportunity to 
gather data on enablers and obstacles to high coverage.(8) Through these surveys, knowledge of 
caregivers and health care workers on the VAS program can be assessed.(8) The strength of these 
surveys is a reduction in recall bias, since they are usually conducted a short while after vitamin A 
campaigns or activities.(8) During such surveys, caregivers are usually shown vitamin A capsules to 
facilitate memory and to avoid confusion with other interventions.(8) Post-event coverage surveys can 
serve as a useful way of balancing out inconsistencies which may be inherent in tally sheet reports.(8) 
Such surveys can be conducted using the standard WHO EPI cluster sampling methodology.(8) 
12 
 
2.4 SUMMARY OF CHAPTER 
The importance of vitamin A and the consequences of its deficiency were described in this literature 
review. Two-stage cluster sampling was highlighted as a highly effective method of measuring 
coverage. It is apparent from this literature review that there are a number of common themes 
suggested by different studies in terms of barriers to children receiving VAS. These include education 
levels of caregivers, whether caregivers live in rural or urban setting, and income levels of caregivers as 
well as knowledge levels on vitamin A. Further research is needed to establish whether similar patterns 
are seen in the South African context, and more specifically, in the context of Amajuba Health District. 
Health system factors which may influence VAS coverage according to cited literature includes 
shortage of vitamin A capsules, missed opportunities for VAS at clinics as well as lack of training of 




3 CHAPTER III: JOURNAL ARTICLE MANUSCRIPT 
In this chapter, I am presenting a Journal Article Manuscript which describes the new research that I 
completed as part of my Master of Public Health degree at the University of KwaZulu-Natal. I have 
prepared the article to be submitted to the South African Medical Journal. In the appendices (Annexure 
E) I have included a summary of the Instructions to Authors for this journal. The type of article is an 
original research article and should be between 3000 and 4000 words. Although this article has not yet 
been published, it should be ready to be sent off to the editors for peer review.  
I have numbered the lines to assist you if you have comments to make. I have included the Tables and 
Figures where I think they could be included in the final published article – as opposed to being 
submitted separately as required by the editors. 
There are some additional results, discussion and limitations, which were not included in the article in 
Chapter 4 of this dissertation.     
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Vitamin A is required for normal development, defence of the immune system and for maintaining 
good eye health in infants and children. Vitamin A deficiency is a major public health problem globally 
and in South Africa. Routine supplementation with high-dose Vitamin A has been a strategy employed 
to reduce the burden of Vitamin A deficiency in children aged from six to 59 months. Coverage of 
vitamin A supplementation (VAS) however remains low in older children in South Africa particularly 
in Amajuba Health District. 
Objectives:  
The objectives of this study are to measure VAS coverage and factors associated with poor VAS uptake 
in this District. 
Methods 
An analytic cross sectional study design was used. A two-stage cluster-sample method was used to 
select the participants. The study population involved mothers and caregivers of children aged 12 to 59 
months residing in Madadeni, a township in the District. The study sample of 198 comprised six 
participants from 33 randomly selected clusters. Data was collected using a field-worker administered 
structured questionnaire. The study received ethical approval (BE 368/15) and was conducted with 
participant’s consent.  
Results 
The coverage of VAS amongst these children was 57% (95% CI: 49 - 63).  Younger children (18 to 23 
months) had better (Prevalence Ratio (PR) 1.2 (95% CI: 0.8 - 1.6) coverage than older children.  
Children who were up to date with VAS coverage were significantly more likely to have received a 
measles vaccine (p<0.01).  A significant association was found between VAS status of children and 
caregivers being able to identify the blue capsules as the 6 to 11-month dose and the red capsules as the 
12 to 59-month Vitamin dose capsule.  There was a non-significant but positive association of a child 
having received VAS and higher level of education of the caregivers, shorter distance from health 




Conclusion and Recommendations   
Amajuba Health District had a VAS coverage of 57% which is below the national target of 65%. The 
low levels of knowledge about Vitamin A among caregivers is a concern, despite knowledge being 
weakly associated with VAS uptake in children.  Health workers need to provide better education for 
caregivers about Vitamin A.  Focus should also be placed on the caregivers of older children as they 
are more likely miss VAS doses. 
Word count: 385 words 
Key words:  Community-based coverage survey; South Africa;  




Introduction   
Vitamin A is an important nutrient required for normal growth and development of infants and 
children, for integrity of the immune system and for good eye health. [1] Vitamin A deficiency (VAD) 
is a major public health problem, worldwide, but also in many middle-income countries, including 
South Africa (SA) with many children being affected. [2] According to the World Health Organisation 
(WHO), a country with a VAD prevalence of greater than 20% has a public health problem that can 
impact child health. [3]  Globally it is estimated that 190 million (95% Confidence Interval (CI): 170 - 
202) or 33% of preschool children are estimated to have VAD (serum retinol <20µg/Dl). [4] [5]  The 
South African National Food Consumption Survey (NFCS) in 2005 reported that the prevalence of 
VAD in children aged 1 to 9 years was 64% in a representative sample of 3120 children. [5] The 
prevalence of VAD reported in the 2013 South African National Health and Nutrition Examination 
Survey (SANHANES) was 44% (95% CI: 36 - 51) for children under the age of five years. [3]  Data 
from the South African Vitamin A Consultative Group (SAVACG) reported a VAD prevalence of 34% 
in the year 2000 for children under 4 years. [6] 
Vitamin A is a crucial nutrient for normal growth and development, for a strengthened immune system 
and for eye health. [7] Thus, children with VAD have increased vulnerability to childhood illnesses and 
infections including measles and diarrhoeal diseases. One of the earliest signs of VAD is nyctalopia 
(night blindness). More severe VAD is a risk for xerophthalmia and blindness. [7] Globally, in 2013, it 
was estimated that 4 million children under the age of 5 years were affected by xerophthalmia. [7] The 
WHO estimates VAD contributes to 6% of under-five child deaths in Africa [8], while vitamin A 
supplementation (VAS) can lead to a 23% reduction in all-cause mortality among children. [5]  
Strategies thus need to be in place to reduce the burden of VAD. 
Globally, advocacy initiatives to implement VAS in many countries as a strategy to improve child 
survival began in 1997. [9] Vitamin A supplementation is one of approaches employed by the SA 
Department of Health (DoH) to reduce VAD, thus improving child health and moving towards 
achieving Sustainable Development Goal number 3 which is about ensuring healthy lives and 
promoting well-being for all ages. [5] [10]  
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The indicator for VAS coverage as defined by UNICEF is the percentage of children aged six to 59 
months who have received two age appropriate VAS capsules at six-month intervals in the past 12 
months. [11]  The denominator is multiplied by 2 as children routinely should receive 2 doses 
annually.[5]  Routine VAS tends to be higher among the younger age groups (6 to 11 months) in 
comparison to the older age groups (12 to 59 months),[8] mainly due to children in the older age group 
accessing health services less often. [12]  
The United Nations Children’s Fund (UNICEF) reported global coverage of VAS in 2011 was 75% for 
children receiving at least two VAS doses annually. [13]  The 2016 national coverage of VAS in SA is 
52%, which is below the national target of 65%. [12]  The coverage in Amajuba Health District (AHD) 
is 54% and the coverage is lower in children aged from 12 to 59 months despite the health service 
being freely available at all primary health care facilities in SA.[5]  Most national, provincial and district 
VAS coverage information in SA is calculated from routine administrative data. Tick register data 
collected at service points where vaccines and VAS is administered is used together with data from 
ward-based outreach teams who also administer Vitamin A when they visit homesteads as part of the 
‘Reengineering Primary Health Care’ policy in the country. [14] There are no community-based surveys 
of VAS coverage reported from SA. 
As VAS coverage indicators are routinely calculated in AHD by administrative means, community-
based measures of coverage as well as the knowledge, attitudes and practices of caregivers of children 
from different age groups about VAD and VAS is not known. Accurate measures of the prevalence of 
VAS coverage and understanding the reasons some children have not had VAS could help influence 
policy and practice of this component of the Expanded Programme on Immunization in SA. [1] 
The purpose of this study was to measure community-based VAS coverage in children aged 12 to 59 
months in 2016 in AHD and to investigate the understanding of VAD and VAS by mothers and 





A community-based observational, analytic cross sectional study design was used for this 
implementation research.  The study population was mothers and caregivers of children aged 12 to 59 
months in Madadeni, a predominantly urban township with some rural sections in the Newcastle sub-
district of AHD of KwaZulu-Natal (KZN).  A two-stage cluster-sample method was used to select the 
sample. Selection of the 33 clusters was done using a 1:8000 scale map of Madadeni. A 2cm by 2cm 
grid was drawn on the map resulting in 450 numbered 4cm2 squares that covered the study area. Each 
square was a cluster. A random sample of 33 clusters was selected.  In each cluster (square), a random 
starting point was identified as the house closest to the centre of the square and the next six houses to 
the right were sequentially visited similar to the methods described in the Expanded Programme of 
Immunisation 30 X 7 Coverage Survey method. [15]   The 33 X 6 two-stage cluster sampling method 
used in this study yielded a total of 198 participants. The sample size of 198 was calculated using 
EPIINFO. The study population was assumed to be more than 1000; the coverage used was 50%; with 
10% variability; and with 95% confidence limits. More clusters than the standard 30 in the EPI 30 X 7 
method were used, as accessing clusters in the township was relatively easy.  
In this present study, the VAS coverage reported was an indication of the proportion of children aged 
12 to 59 months receiving one dose of VAS within a period of 6 months, thus the denominator was not 



















Figure 1: Process of final sample selection for VAS coverage survey 
A total of 106 households had more than one child under 5 years, however no household had more than 
one child sampled for the study. Data was collected using a field-worker administered structured 
questionnaire at household level. The questionnaire is based on the UNICEF Multiple Indicator Cluster 
Survey (MICS).[15]  To improve content and face validity the questionnaire was translated into isiZulu 
and pilot tested on 10 mothers at a clinic.  
In order to minimize interviewer bias, the two field workers received standardised training on the 
content and administration of the questionnaires and uniform collection and recording of data. The data 
collection forms were checked by the principal investigator (PI) on a daily basis. The importance of 
maintaining the confidentiality of participant information was communicated to the participants to 
Households visited 
(n=257) 
Nobody home/no child of correct age 
(n=56) 






Follow up visits 
(n=12) 
Completed questionnaires, included in 
analysis (N=198) 
Declined participation (n=2) 
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ensure that there was limited respondent bias or likelihood of participants responding in a socially 
desirable manner. To minimize recall bias, participants were shown a Vitamin A capsule to aid 
memory with regard to questions on VAS.  Coverage of VAS was verified by checking Road to Health 
Booklet (RtHB) entries, in addition to subjective caregiver reports. 
Data was entered into Microsoft Excel and analysed using STATA statistical software. Analytic 
statistics were used to measure associations and compare differences between children who had or had 
not received VAS. The null hypothesis stated that there is no difference in characteristics between the 
two groups and the significance level was set at 0.05. The two-independent samples t-test was used to 
test for equality of means of numeric continuous variables between the two groups of children. Pearson 
Chi-squared tests were used to test for equality of proportions for different categorical variables 
between the two groups.  
The study was approved by University of KwaZulu-Natal Biomedical Research Ethics Committee (BE 
368/15) and the KZN DoH Research Committee. Both written and verbal informed consent was 
obtained from participants at the time of the interview. The purpose of the survey was explained to 
participants and included in the participant information sheet in isiZulu. The appropriate Vitamin A 
capsule dose was offered to children who were eligible.  
Results  
Sample demographic characteristics 
The mean age of the 198 children aged 12 to 59 months included in the study investigating VAS 
coverage and understanding in Madadeni was 33 months (Standard Deviation (SD) 15) and that of the 
child’s caregivers was 33 years (SD 13) - range 11 to 88 years. Most of the caregivers were single (170, 
86% - 95% CI: 80 - 90), African (196, 98% - 95% CI: 96 - 99) females (194, 97% - 95% CI: 95 - 99), 
and lived in an urban area (157, 79% - 95% CI: 73 - 84).  Two thirds (130, 66% - 95% CI: 56 - 72) 
were unemployed and social grants or pensions were the main source of income (161, 81% - 95% CI: 
75 - 86). The majority of caregivers (120, 60%) had 12 or more years of education. Most of the 
respondents (117, 59% 95% CI: 52 - 66) reported an average household monthly income of between 
R1000 and R5000. Most caregivers reported that the household they lived in was “very close” to a 
health facility (108, 54% - 95% CI: 47 – 61) while (30, 15% - 95% CI: 10 - 20) reported living “very 
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far” from a health facility.  Most of the caregivers reported that their mode of transport for travelling to 
clinics was walking (126, 64% 95% CI: 57 - 70) and it took them less than an hour to travel to the 
clinic (168, 85% - 95% CI: 79 - 89).  A median of eight people lived in a household with two being 
children under five years.  More than two-thirds (135, 68% - 95% CI: 61 - 74) of the children were not 
attending any early child development (ECD) centre and those that did attend an ECD centre (44, 69% 
95% CI: 57 - 80) spent one to seven hours per day at the centre.   
Vitamin A supplementation coverage 
Community-based VAS coverage was assessed by determining the proportion of the 198 children 
between 12 and 60 months in the study sample who had received a single dose of VAS within the 
previous six months.  One hundred percent of participants ‘data on coverage was determined by Road 
to Health Booklet and none was determined by verbal report.  The overall VAS coverage (prevalence) 
in children in this study population was 57% (95% CI: 49 - 63). Children aged 18 to 23 months had the 
highest VAS coverage (71%, 95% CI: 65 - 76) and this decreased with increasing age. It was 65% in 
the 24 to 35-month age group, 49% in the 36 to 47-month age group and a low of 44% in children aged 
48 to 59 months.  
The children of mothers and caregivers older than 35 years had the best VAS coverage (79%, 95% CI: 
76 - 82). This was 72% and significantly higher relative to the youngest group of caregivers 
(Prevalence Ratio (PR 1.27, 95% CI: 1.15 - 2.13).  
A child who had received their first dose of Vitamin A even one day after 6 months and not at 6 
months; and/ or subsequent doses after more than 6 months was classified as having received vitamin A 
late. The majority (111, 56% - 95% CI: 49 - 62) of the children had received their first dose of vitamin 
A late, a trend was observed with the second dose of VAS as well (112, 56% - 95% CI: 49 - 63). Most 
children, (127, 64% - 95% CI: 57 - 70) in the study had received their last dose of vitamin A at a health 
facility during a routine Well-Baby Clinic visit, while (32, 16% 95% CI: 11 - 22) had received their last 
dose during an immunization campaign, which are usually held at ECD centres in the district. Only one 
child had received a VAS dose at home from a community caregiver and the rest (16, 8% 95% CI: 5 - 
13) had received a VAS dose when they had attended the health facility for an illness.  
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The majority of caregivers interviewed (151, 76% - 95% CI: 69 - 81) were sure their children had 
received at least one vitamin A capsule, 43 (21% - 95% CI: 16 - 27) were not sure their child had 
received VAS and 6 (3% - 95% CI: 1 - 7) were sure their child had never received VAS. However, on 
review of the RtHBs, it was confirmed that only 5 (2% - 95% CI: 1 - 5) children had never received 
vitamin A supplementation before. Most (146, 73% - 95% CI: 67 - 79) of the caregivers did not know 
when the last dose of vitamin A was given.   
Caregivers knowledge about Vitamin A was assessed and most (141, 71% - 95% CI: 64 -77) reported 
having never been informed by a health worker of the importance for their children to receive VAS. As 
a result, most (150, 75% - 95% CI: 69 - 81) did not know the VAS dose frequency of vitamin A, and 
very few (33, 16% 95% CI: 12 - 22) knew that VAS should be given six monthly.  There was very little 
knowledge among the caregivers on identifying and differentiating between the different doses of the 
vitamin A capsules. Only 14 (7% 95% CI: 4 - 12) correctly identified the ‘blue’ (6 to 11 month) VAS 
dose capsule and 32 (16% 95% CI: 12 – 22) identified the ‘red’ (12 to 60 months) dose Vitamin A 
capsule.  Most also were unaware when the first dose of VAS should be given, (146, 73% - 95% CI: 67 
- 79), and only (28, 14% - 95% CI: 9 -19) correctly stated that the first dose should be at six months of 
age. There was also very little knowledge about the side effects of VAS among the caregivers. Only 23 
(12%) of the mothers and caregivers were able to list side effects of VAS and 49 (35%) were aware of 
the benefits of VAS. The reduction of childhood illness was the most frequently mentioned benefit (38, 
19% 95% CI: 14 – 25) among those caregivers who could list some benefits.  Health facilities were the 
most frequently reported place where caregivers heard about vitamin A, where 139 (70% 95% CI: 63 - 
76) of the caregivers reported that they usually hear about vitamin A at health facilities.      
Immunization and weight  
Assessing the nine and 18-month measles immunisation status among children in the study population 
and relating this with VAS coverage was also analysed as part of the study. Most (184, 93% - 95% CI: 
88 - 96) of the 198 children had been vaccinated for measles at least once according to what was 
recorded on the RtHB. The majority (124, 63% 95% CI: 54 - 72) had received both doses of measles 
vaccine, (53, 27% 95% CI: 24 - 30) only the 9-month dose and 4 (2%) had only received measles 
vaccine at 18 months.   Sixty-one (97% 95% CI: 74 - 119) of the 63 children aged 12 to 23 months had 
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received the 9-month dose of measles vaccine. There was a statistically significant association (p<0.01) 
between children having been immunised for measles and receiving VAS.  Children who had VAS 
were 2.7 times more likely to have had measles vaccination. Children who had received no measles 
vaccination were 0.88 times less likely to receive VAS (95% CI: 0.80 – 0.96). 
Caregiver knowledge of their children’s growth patterns was assessed through questions about their 
child’s previous weight recording. It was found that only 27% (95% CI: 21 - 34) correctly recalled their 
child’s previous weight. 
Associations between VAS status and respondent characteristics 
The association between VAS coverage and a number of independent variables was assessed. 
Caregivers with less than 10 years of education had the best VAS coverage (61%) and although the 
coverage was slightly lower with increasing education levels, this was not statistically significant 
(p=0.93). Children with caregivers who were pensioners had with the highest VAS coverage (62%) 
followed by those unemployed (58%) and children of employed care givers had the lowest coverage 
(40%) (p=0.18). The best coverage (62%) was in those with a reported monthly income of less than 
R1000.   
No significant association was found between marital status of caregivers and VAS status of children 
(p=0.25). No significant association was found between whether children lived in an urban or rural 
area. 
Statistically significant associations were found between VAS status of children and the ability of 
caregivers to correctly identify and differentiate the blue capsules of Vitamin A (p=0.03) and the red 
capsules of Vitamin A (p=0.03).   
No significant association was found between VAS status of children and the ability of caregivers to 
correctly recall their child’s previous weight (p= 0.08).   
In testing hypotheses of association between VAS status of children and some numerical variables such 
as caregiver age in years and children’s age in months, the independent samples t-test was used, with 
the significance level also set at 0.05.  No significant association was found between VAS status of 
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children and age of their caregivers (p=0.98).  No significant association was found between VAS 
status of children and number of people living in one household (p=0.10) as well as the number of 
children living in the same household (p=0.34). However, there was a significant association found 
between VAS status of children and age of children (p=0.03).  The mean age of those children who 
were found to be up to date in VAS was 31 months (95% CI: 28 - 33) and the mean age of those who 




Table 1: Relationship between respondent characteristics of caregivers of children aged 12 to 59 months and VAS 
receipt in 2016 
    Number of Children       
Independent variable category Sub-variable Vit A given 
Vit A not 
given Prevalence  
Prevalence 
Ratio PR 95% CI 
Age of Child (months) 12-17 23 15 60.5% Reference 
 
 
18-23 22 9 71.0% 1.17 0.83 to 1.65 
 
24-35 24 13 64.9% 1.07 0.76 to 1.52 
 
36-47 25 26 49.0% 0.81 0.55 to 1.18 
 
48-60 18 23 43.9% 0.73 0.47 to 1.12 
Age of Caregiver (years) <=24 years 37 25 62.7% Reference 
 
 
25 to 35 years 42 32 50.8% 0.81 0.61 to 1.08 
 
>=36 33 29 72.1% 1.15 0.84 to 1.57 
Current Occupation Unemployed 75 55 57.7% Reference 
 
 
Scholar 16 13 55.2% 0.96 0.67 to 1.37 
 
Employed 13 13 50.0% 0.87 0.57 to 1.31 
 
Pensioner 8 5 61.5% 1.07 0.68 to 1.68 
Source of Income Salary/wage 8 12 40.0% Reference 
 
 
Grant 96 65 59.6% 1.49 0.86 to 2.59 
 
Other 8 9 47.1% 1.18 0.70 to 1.98 
Education Level < 10 years 30 19 61.2% Reference 
 
 
10 -12 years 58 43 57.4% 0.94 0.71 to 1.24 
 
Higher 24 24 50.0% 0.82 0.57 to 1.17 
Area of Household Urban 90 67 57.3% Reference 
 
 
Rural 22 19 53.7% 0.94 0.68 to 1.28 
Average household income < R1000 33 20 62.3% Reference 
 
 
between R1000 & R5000 66 51 56.4% 0.91 0.70 to 1.18 
 
>R5000 13 15 46.4% 0.75 0.48 to 1.17 
Measles immunisation 9 + 18 months 75 49 60.5% Reference 
 
 
9 months 31 22 58.5% 0.97 0.74 to 1.26 
 
Other time 4 3 57.1% 0.94 0.49 to 1.93 
 
No immunisation 2 12 14.3% 0.24 0.06 to 0.86 
Measles immunisation Yes 110 74 59.8% Reference 
 
 
No 2 12 14.3% 0.24 0.07 to 0.87 






In 2015/16, the VAS coverage was reported as 54% which was well below the 2015/16 national target 
of 65%.2  The community-based VAS coverage in this study of 57% (95% CI: 49 - 63), which is not 
substantially different to that reported. 
The community-based and administrative methods for measuring coverage in this District are very 
similar suggesting that monitoring the coverage using administrative methods gives a good indication 
of the actual coverage.  Previous studies comparing community based and administrative methods of 
monitoring coverage have found differences in the results of the two methods.[16]  Although there was 
little difference shown in this study between community-based and administrative methods, it is 
necessary to have community-based surveys as a validation method and this might be done at least 
once a year.  
The district coverage of 57% as found in this study was not very different compared to the reported 
KZN provincial coverage of 55% in 2014/15 as well as the national coverage of 52% in 2014/15.  The 
coverage of 57% for Amajuba Health District was higher than other districts in KZN including 
UMkhanyakude Health District which had VAS coverage of less than 40% in 2014/15.  The Amajuba 
District coverage of 57% however is still lower than the coverage in better performing districts such as 
UMzinyathi which had coverage of above 58% in 2014/15.   
A number of previous studies reported a strong association between lower levels of caregiver education 
and children not being up to date in receiving Vitamin A.[1] The findings of the current study were 
similar to a study done in Tanzania which also  found no significant association between caregiver 
education levels and VAS status of children.[16]  The Tanzania study was also community-based and 
used the EPI cluster sampling methodology with a considerably larger sample size than the current 
study (30 by 40 clusters, n=1200). Although not significant, a higher education and income was 
associated with not receiving vitamin A.  This may be attributed to a tendency of caregivers in this 
                                                 
2 Data obtained from district health information system 2016 
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category to make less use of public health facilities and rather use private facilities such as private 
doctors.    
While a strong association between children receiving vitamin A and a higher caregiver income was 
reported by a 2013 study in India, the present study found no significant association between caregiver 
income level and receipt of vitamin A by children.  Findings of the study in India was from a cross-
sectional study of 20 802 children aged 12 to 35 months whose mothers participated in a national 
survey thus was more representative.[7] 
The 2012 study conducted in Nepal found a strong association between children not being up to date 
with VAS and living in a rural area, while no such association was found between VAS status of 
children and area of household in the present study.  The Nepal study however was a nationally 
representative survey with a sample of 4013 children aged 12 to 59 months.[1]  The present study 
however had unequal representation of participants living in urban area and rural areas, and the 
majority lived in urban areas.   
Similar to findings reported by a 2011 study in the Western Cape SA, the present study found that a 
low percentage of mothers and caregivers had knowledge of why children receive vitamin A 
supplementation and very few mothers had been informed by a health worker on vitamin A.  
Caregivers in this study had very little knowledge on the health benefits of receiving VAS and on how 
often their children should receive a dose.  A majority of the caregivers reported health facilities as the 
place where they heard about vitamin A, yet a majority also reported they had not been informed by a 
health worker on why vitamin A is given to children.  This may be an indication that health workers do 
share with caregivers that they are giving vitamin A, but are not sharing important information on why 
vitamin A is given.  However, there was no significant association found in the present study between 
caregiver knowledge on VAS and receipt of vitamin A by children. 
The majority of caregivers reported living very close to a health facility, with most reporting that it 
usually took them less than an hour to travel to the nearest health facility, however this was found not 
to be associated with children receiving vitamin A.  This is an indication that caregivers can have close 
access to health facilities yet not take their children to receive VAS. The responses for this question 
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were very subjective however, as how close or far a health facility was reported depended on the 
opinions and perceptions of respondents. 
Study Limitations 
This study had a relatively small sample size in comparison to previous studies referred to in the 
literature.  Data could only be aggregated and the sample of 198 did not allow for a great deal of 
inference.  Once a cluster was obtained; sequential / convenience sample of 6 households in the cluster 
was used. This was a limitation since children within the same cluster are likely to have similar 
characteristics, such as proximity to a health facility and access to services.  This may have presented a 
form of selection bias.  There was a race and gender imbalance in the study sample, which also 
presented a form of selection bias, with African female caregivers having the highest representation.  
This may have led to great similarity in characteristics.  There was also a limitation in the design of the 
study, since this was a cross sectional study, exposures and outcomes were measured at the same time 
thus a strong case for causality could not be established.  Since the principal investigator was 
introduced as both a research student and as a Department of Health worker, some information bias 
may have been introduced as participants may have felt a need to give favourable responses.  The study 
was conducted in one area within the sub-district of Newcastle and this area is mostly urban.  This was 
a limitation since the data may not be generalizable to the whole of AHD, particularly areas that are 
more rural.  Despite these limitations, the findings of this study may not be sufficient to warrant a 
change of policy and but they may be used as a basis for improving current practice and some valuable 






The low levels of knowledge among caregivers regarding Vitamin A found in this study were 
concerning, despite there being no significant association found between VAS status of children and 
knowledge levels of caregivers.  Thus, it is recommended that emphasis be placed on focusing training 
of health workers on the importance of educating caregivers on the reasons for giving Vitamin A.  
Focus should also be placed on the older age groups of children as they are more likely miss VAS 
doses.  This can be done by scaling up community outreach activities aimed at finding children at 
community level and providing them with the service of VAS.  ECD and household visits should assist 
in reaching children of the older age group who may not be accessing health facilities regularly.  Such 
outreach activities should also include an element of providing health education to mothers and 
caregivers informing them of the importance of VAS along with other essential child health services 
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4  IV: ADDITIONAL FINDINGS, 
DISCUSSION AND LIMITATIONS 
4.1 INTRODUCTION  
This study focused on vitamin A supplementation in children aged between 12 to 59 months in 
Amajuba Health District and aimed to measure coverage of VAS in the district as well as to assess 
whether there an association between VAS status in children aged 12 to 59 months and caregiver and 
child characteristics. In this chapter, additional findings of the study will be discussed along with a 
discussion on the methods used to ensure validity of the study as well as a discussion on limitations of 
the study.  
4.2 ADDITIONAL FINDINGS  
Table 1 shows the additional findings of the study. Most caregivers reported that the household they 
lived in was “very close” to a health facility (108, 54% - 95% CI: 47 – 61) while (30, 15% - 95% CI: 
10 - 20) reported living “very far” from a health facility, however this was found not to be associated 
with children receiving vitamin A. This is an indication that caregivers can have close access to health 
facilities yet not take their children to receive VAS. Most of the caregivers reported that their mode of 
transport for travelling to clinics was walking (126, 64% 95% CI: 57 - 70) and it took them less than an 
hour to travel to the clinic (168, 85% - 95% CI: 79 - 89). No significant association was found between 
VAS status and: distance of respondent household from the nearest health facility (p=0.27); the mode 
of transport used to reach health facilities (p=0.93); the time it takes to travel from home to a health 
facility (p=0.47). It was concerning to find low levels of knowledge on vitamin A supplementation 
among mothers and caregivers and very few mothers had been informed by a health worker on vitamin 
A, (141, 71% - 95% CI: 64 -77) reported having never been informed by a health worker of the 
importance for their children to receive VAS. Most caregivers were also unaware when the first dose of 
VAS should be given, (146, 73% - 95% CI: 67 - 79), and only (28, 14% - 95% CI: 9 -19) correctly 
stated that the first dose should be at six months of age. There was also very little knowledge about the 
side effects of VAS among the caregivers. Only 23 (12%) of the mothers and caregivers were able to 
list side effects of VAS and 49 (35%) were aware of the benefits of VAS. No significant association 
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was found between VAS status of children and whether caregivers had the correct knowledge on how 
often children should receive VAS (p=0.27) and knowledge on the correct age of receiving the first 
dose of VAS (p=0.81). No significant association was found between a caregiver having ever been 
informed by a health worker on why children received VAS and the VAS status of children (p=0.81). 
No significant association between VAS status of children and caregiver knowledge on the benefits of 
receiving vitamin A (p=0.99) and knowledge on the possible side effects of vitamin A (p=0.65). The 
reduction of childhood illness was the most frequently mentioned benefit (38, 19% 95% CI: 14 – 25) 
among those caregivers who could list some benefits. A majority of the caregivers reported health 
facilities as the place where they heard about vitamin A, yet a majority also reported they had not been 
informed by a health worker on why vitamin A is given to children. This may be an indication that 
health workers do share with caregivers that they are giving vitamin A, but are not sharing important 
information on why vitamin A is given. However, there was no significant association found in the 
present study between caregiver knowledge on VAS and receipt of vitamin A by children. There was 
also no significant association found between VAS status of children and the place where caregivers 
heard about Vitamin A (p=0.59). 
Table 2: additional characteristics of caregivers of children aged 12 to 59 months in Amajuba 
Health District 2016 and VAS receipt. 
    Number of Children       
Independent variable category Sub-variable Vit A given 
Vit A not 
given Prevalence  
Prevalence 
Ratio PR 95% CI 
Mode of transport to health facility Private car/public transport 40 32 55.6% Reference 
 
 
Walking 72 54 57.1% 1.03 0.83 to 1.65 
Time to reach health facility < 1 hour 94 74 56.0% Reference 
 
 
>=1 hour 18 12 60.0% 1.07 0.78 to 1.48 
Informed by health worker Yes 33 24 57.9% Reference 
 
 
No 79 62 56.0% 0.97 0.74 to 1.26 
Caregiver knowledge on first dose of VAS 
At 6 months 16 12 57.1% Reference 
 
Do not know 96 74 56.5% 0.99 0.70 to 1.40 
Caregiver knowledge on side effects of VAS 
Correct side effect named 16 7 69.6% Reference 
 
Do not know/incorrect answer 96 79 54.9% 0.79 0.58 to 1.07 
Caregiver knowledge on health benefits of VAS  
correct benefit named 35 25 58.3% Reference 
 
Do not know/incorrect answer 77 61 55.8% 0.96 0.74 to 1.24 





Radio/television/newspaper 13 14 48.1% 0.82 0.54 to 1.24 
 
Family/friends 5 5 50.0% 0.85 0.45 to 1.60 
 
Other  10 6 62.5% 1.06 0.71 to 1.59 
 
Never heard of vitamin A 2 4 33.3% 0.69 0.21 to 2.29 
 
Total 112 86 56.6% 
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4.3 BIAS, LIMITATIONS OF RESULTS AND STUDY DESIGN 
4.3.1 Measurement validity 
Measurement validity is the extent to which an assessment measures what it is intended to measure. 
Defining household distance from the nearest health facility was determined subjectively based on 
participants’ perceptions of what is “near” “far” and “not so far”. This was a limitation as it would have 
been more objective to measure actual distance of each household from the nearest facility and have a 
standard definition of what is considered far and near. 
4.3.2 Statistical conclusion validity 
Statistical conclusion validity is the extent to which conclusions about the relationship among variables 
based on data are correct. Pearson- Chi tests were used to measure associations between categorical 
data and two sample t-tests were used to test for association of numerical data with the independent 
variable. Significance level was set at 0.05. The coverage of VAS amongst children was 57% (95% CI: 
49 - 63). Younger children (18 to 23 months) had better (Prevalence Ratio (PR) 1.2 (95% CI: 0.8 - 1.6) 
coverage than older children. Children who were up to date with VAS coverage were more likely to 
have received a measles vaccine and this was statistically significant (p<0.01). The association between 
receiving measles vaccine and receiving VAS is however not surprising as the EPI programme is 
designed such that children are given VAS during immunisation visits. A significant association was 
found between VAS status of children and caregivers being able to identify the blue capsules as the 6 to 
11-month dose and the red capsules as the 12 to 59-month Vitamin dose capsule. There was a non-
significant but positive association of a child having received VAS and higher level of education of the 
caregivers, shorter distance from health facilities, living in an urban area and having received 
information about VAS from a health worker. A larger sample size may have given the study more 
power and rendered some of the findings statistically significant. 
4.3.3 Internal validity 
Internal validity is the extent to which the findings of a study are due to the exposure being measured 
and not some other cause. Data collectors were given uniform training on how to administer the 
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questionnaires to ensure that there is limited variation in the mode of data collection which can threaten 
internal validity. There was a limitation in the design of the study, since this was a cross sectional 
study, exposures and outcomes were measured at the same time thus a strong case for causality could 
not be established. Since the principal investigator was introduced as both a research student and as a 
Department of Health worker, some information bias in the form of the Hawthorne effect may have 
been introduced as participants may have felt a need to give favourable responses. Data collectors also 
had a tendency of asking leading questions by mentioning some of the possible responses to questions 
instead of just letting the participants respond. A pilot test of the questionnaire was conducted to 
improve reliability of the questionnaire and adaptations were made based on findings. Lack of 
multivariate analysis and attempt to control for clusters was a key weakness of the study design and 
this compromised the value of conclusions drawn.     
4.3.4 External validity 
External validity refers to the extent to which the results of a study can be generalized to a wider 
population. This study had a relatively small sample size in comparison to previous studies referred to 
in the literature. Data could only be aggregated and the sample of 198 did not allow for a great deal of 
inference. The study setting was mostly urban thus, the results of the study may not be able to be 
generalizable to more rural areas. Once a cluster was obtained; sequential / convenience sample of 6 
households in the cluster was used. This was a limitation since children within the same cluster are 
likely to have similar characteristics, such as proximity to a health facility and access to services. This 
may have presented a form of selection bias. There was a race and gender imbalance in the study 
sample, which also presented a form of selection bias, with African female caregivers having the 
highest representation. This may have led to great similarity in characteristics.  
4.4 SUMMARY OF CHAPTER  
This chapter summarised the additional findings arising from the research, as well as limitations and 




5 CHAPTER V: CONCLUSIONS AND RECOMMENDATIONS  
5.1 INTRODUCTION 
This study focused on investigating VAS coverage in children aged 12 to 59 months in Amajuba 
Health District as well as comparing the characteristics of children who were up to date with VAS with 
children who were not up to date with VAS. In this final chapter, findings of the study; in line with the 
study aims and objectives; will be discussed and interpreted. This chapter will also present 
recommendations for practice and policy as well as recommendations for further studies in the topic. 
5.2 CONCLUSIONS 
The District Health Barometer reported a VAS 12 to 59 months coverage of 50% in Amajuba District 
in 2014/15 which was below the then national target of 55%. The present study estimated a VAS 
coverage of 57% in Amajuba District for 2016, indicating that the district has still not reached the 
target of 65% for 2016. 
A number of studies have been conducted previously to compare the characteristics of children who are 
up to date in receiving VAS with those of children who are not up to date. Some of these studies have 
found associations between some of these characteristics and VAS status of children. For instance, 
some studies found a strong positive association between lower caregiver education levels and children 
not receiving VAS. Other studies found a significant association between children residing in rural 
areas and not receiving VAS. The present study however found no significant association between 
children receiving VAS and many of these characteristics; including caregiver education level, income 
level, and caregiver age, area of household and even proximity to health facilities. No significant 
associations were found between VAS status of children and caregiver access to media and 
information, to caregiver being informed by a health worker on VAS and knowledge of caregivers on 
VAS benefits and side effects. 
The study did find a strong association between VAS status of children and age of children; where it 
was found that older children were more likely to not be up to date with VAS than younger children. 
This trend has also been reported by other studies. A significant association was also found between 
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VAS status of children and having received a measles vaccine. A significant association was also found 
between VAS status of children and whether caregivers could correctly identify the different Vitamin A 
doses.  
Overall, there was very little knowledge amongst the caregivers on vitamin A, including its benefits 
and when it should be given. A high percentage of caregivers also reported not being informed by 
health workers on the reasons that their children receive vitamin A. 
5.3 RECOMMENDATIONS  
1. Although in this study no significant association was found between VAS status of children and 
caregiver knowledge on vitamin A as well as whether caregivers were informed by health 
workers on vitamin A; the low levels of knowledge on VAS among caregivers is concerning 
and should be addressed.  It is recommended that health workers in direct contact with 
caregivers are trained and encouraged to place more emphasis on sharing information with 
parents on why vitamin A is given to children.  The intended outcome of this recommendation 
would be to raise awareness among caregivers on VAS and hopefully increase their behavior of 
seeking this health service.  To achieve this health care workers need to be invested and 
committed to advocacy for the service. 
2. Anecdotal accounts indicated some caregivers thought that children should only be taken to 
health facilities when they are sick or for immunisations and most were not aware of the six-
month intervals of receiving VAS.  It is thus recommended that caregivers are informed of the 
importance of children receiving VAS, this should motivate them to take their children to health 
facilities to receive this service.  It has been shown in previous studies that educating caregivers 
increases their likelihood of practicing beneficial caregiving health behaviours.(1) There have 
been great successes in emphasizing and promoting the importance of immunisations to 
caregivers as can be seen in the high immunisation coverage shown in previous studies and the 
present study.  The same efforts should be put into promoting vitamin A supplementation.  
There has also been great success in combining vitamin A supplementation with EPI services 
and in this study a strong association was found between children being up to date with VAS 
and having received their measles immunisations.  However it is not sufficient to merely 
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combine the two services but education on both services should be given to caregivers.  In 
addition to informing caregivers on the importance of VAS it is also recommended that they are 
educated on dietary diversification and consuming Vitamin A rich foods.(2) 
3. This study found that lack of VAS was found more in older children thus emphasis needs to be 
placed on older children, particularly those older than 18 months as this is when the 
immunisation schedule stops until they are six years old.  It is recommended that more 
campaigns are conducted to target this age group at Early Childhood Development Centres as 
well as awareness campaigns targeting parents to educate them on dose schedules and the 
importance of receiving VAS up until the age of five years.  The intended outcome of this 
recommendation would be to increase the number of older children accessing this service.  To 
achieve this, resources will have to be dedicated to providing outreach services, including 
human resources and transport. 
5.4 RECOMMENDATION FOR FURTHER STUDY 
This study has attempted to estimate VAS coverage and compare characteristics of caregivers of 
children aged 12 to 59 months in Amajuba District, however, sampling was done in only one of the 
three sub-districts. A suitably sized random selection of participants across the district might improve 
the power of the study. The South African Department of Health has deployed ward based outreach 
teams as an effort to improve vitamin A supplementation coverage, however there is little information 
on the impact of this on coverage and it is difficult to assess whether this is being implemented 
sufficiently.(7)  Therefore, more research is needed to explore the level and impact of VAS given by 
outreach teams. Furthermore, research is needed to investigate the integration of data of outreach teams 





1. Nguyen AM, Grover DS, Sun K et al. Coverage of the vitamin A supplementation 
programme for child survival in Nepal: success and challenges. Paediatrics and 
International Child Health; 2012. 32 (4): 233-238. 
 
2. Murray JS, White J.  Vitamin A supplementation in infants and children.  Journal for 
Specialists in Pediatric Nursing; 2016.  21: 212-217. 
 
3. Gorstein J, Parvanta I, Begin F et al. Indicators and Methods for Cross-Sectional Surveys of 
Vitamin and Mineral Status of Populations.  The Micronutrient Initiative (Ottawa) and the 
Centers for Disease Control and Prevention (Atlanta): Atlanta, 2007.  
 
4. South African Department of Health. National vitamin A supplementation policy guidelines 
for South Africa, 2012. National Department of Health South Africa: Pretoria, 2012. 
 
5. Osborn D, Cutter A, Ullah F. Universal Sustainable Development Goals Understanding the 




6. World Health Organisation. Guideline: Vitamin A supplementation in infants and children 
6–59 months of age. 2011. World Health Organisation: Geneva, 2011. 
 
7. Massyn N, Peer N, Padarath A et al. District Health Barometer 2014/15. 2015. Health 
Systems Trust: Durban, 2015.  
 
8. Katcher H, Nankap M, Mkumbwa T et al. Vitamin A Supplementation (VAS) Coverage 
Data in Africa: Modernizing data collection to inform  distribution strategies. Site and Life, 
2014. 28 (2)103-108.  
 
9. Sommer A, West KP.  Vitamin A deficiency: Health, survival and vision.  1996.  Oxford 
university press: New York, 1996. 
 
10. Statistics SA.  Statistics South Africa: Census 2001, Concepts and definitions. 2004. 
Statistics South Africa: Pretoria, 2004. 
 
11. Faber M, Van Jaarsveld JP, Kunneke E et al.Vitamin A and anthropometric status of South 
African preschool children from four areas with known district eating patterns. Nutrition; 
2015(31):  64-71. 
 
12. Shisana O, Labadarios D, Rehle T et al. The South African National Health and Nutrition 




13. Nojilana B, Norman R, Bradshaw D et al. Estimating the burden of disease attributable to 
vitamin A deficiency in South Africa in 2000. South African Medical Journal; 97: 748-753.   
 
14. Agrawal S, Agrawal P. Vitamin A supplementation among children in India: Does their 
socioeconomic status and the economic and social development status of their state of 
residence make a difference? International Journal of Medicine and Public Health; 2013. 
3(1): 48-54. 
 
15. World Health Organisation.  Global prevalence of vitamin A deficiency in populations at 
risk 1995-2005: WHO global database on vitamin A deficiency. Geneva: World Health 
Organisation. 2009. 
 
16. World Health Organisation. Vitamin A supplementation in infants and children  6–59 
months of age. Geneva: World Health Organisation. 2011. 
 
17. Clohossey PC, Katcher HI, Mogonchi GO et al. Coverage of vitamin A supplementation 
and deworming during Malezi Bora in Kenya. Journal of Epidemiology and Global Health; 
2014.4:169-176. 
 
18. Comley V, Nkwanyana N. Immunisation and vitamin A capsule coverage in a semi-urban 
area of KwaZulu-Natal Province, South Africa. South African Journal of Child 
Health.;2015.9(4):108-111. 
 
19. Massyn N, Day C, Peer N et al. District Health Barometer 2013/14. Health Systems Trust: 
Durban, 2014.  
 
20. UNICEF. Improving Child Nutrition: The achievable imperative for global progress. 2013, 
UNICEF: New York,2013. 
 
21. Dhillon CN, Subramaniam H, Mulokozi G et al. Overestimation of Vitamin A 
Supplementation Coverage from District Tally Sheets Demonstrates Importance of 
Population-Based Surveys for Program Improvement: Lessons from Tanzania. PloS ONE, 
2013. 8(3). 1-7. 
 
22. Semba RD, De Pee S, Sun K et al. Coverage of Vitamin A Capsule Programme in 
Bangladesh and Risk Factors Associated with Non-receipt of Vitamin A. Journal of Health 
Population Nutrition; 2010;28(2):143-148. 
 
23. Iversen PO, Hoisaether EA, Morseth M et al. Diverging opinions of supplementation 
programmes between mothers of small children and staff at primary health clinics in the 
Western Cape Province of South Africa. Public Health Nutrition; 2011;14(5):923-930. 
 
24. Du Plessis LM, Najaar B, Koornhof HE et al. Evaluation of the implementation of the 
vitamin A supplementation programme in the Boland / Overberg region of the Western 

















ANNEXURE C: QUESTIONNAIRE 
QUESTIONNAIRE FOR CAREGIVERS OF CHILDREN AGED 12 TO 59 MONTHS   
 
 
UNDER-FIVE CHILD INFORMATION PANEL UF 
 This questionnaire is to be administered to all mothers or caretakers who care for a 
child that lives with them and is under the age of 5 years. 
 A separate questionnaire should be used for each eligible child. 
UF1. Cluster number: UF2. Child number: 
___  ___  ___   ___  ___   
UF7. Interviewer’s name and number: UF8. Day / Month / Year of interview: 
Name       ___  ___ ___ ___ /___ ___ /  2  0  1  ___ 
 
 Repeat greeting if not already read to this respondent: 
 
WE ARE FROM THE UNIVERSITY OF KWAZULU-NATAL AND DEPARTMENT OF 
HEALTH WE ARE CONDUCTING A SURVEY ABOUT THE HEALTH OF CHILDREN, 
FAMILIES AND HOUSEHOLDS. I WOULD LIKE TO TALK TO YOU ABOUT (child’s name)’S 
HEALTH AND WELL-BEING. THE INTERVIEW WILL TAKE ABOUT 30 MINUTES. ALL THE 
INFORMATION WE OBTAIN WILL REMAIN STRICTLY CONFIDENTIAL AND ANONYMOUS. 
 MAY I START NOW?  
 Yes, permission is given   Go to UF12 to record the time and then begin the 
interview. 
 No, permission is not given    Circle ‘03’ in UF9. Discuss this result with your 
supervisor. 
 
UF9. Result of interview for children under 5  
 
   Codes refer to mother/caretaker. 
Completed ...................................................... 01 
Not at home .................................................... 02 
Refused ........................................................... 03 
Partly completed ............................................. 04 
Incapacitated................................................... 05 
Other (specify) ________________________ 96 
 
UF10. Field editor’s name and number: 
 
Name______________________________  __   
 
 
UF11. Main data entry clerk’s name and number: 
 
Name_______________________________  __  __ 
 
Hour and minutes…………………..___   ___: ___  
46 
 




MOTHER/CAREGIVER INFORMATION MC 
Demographic and socioeconomic information   
 MC1.IN WHAT MONTH AND 
YEAR WERE YOU BORN? 
 AGE IN YEARS  
DOB of caregiver:  Day/Month/Year   
___ ___ / ___ ___ / ___ ___ ___ ___    
_________ 
 
 MC2. GENDER OF CAREGIVER  Female…………………………………………1 
Male…………………………………………….2 
 
















 MC5. CURRENT OCCUPATION 





Other (specify) ……………………………….5 
 




Education   





 MC8. WHAT IS THE HIGHEST 
LEVEL OF SCHOOL YOU ATTENDED: 
PRIMARY, SECONDARY, OR HIGHER 
<7 years..................................................0 
7 years...................................................1 





• Access to media and use of information technology  
MC9. HOW OFTEN DO YOU READ A 
NEWSPAPER OR MAGAZINE: ALMOST 
EVERY DAY, AT LEAST ONCE A WEEK, 
LESS THAN ONCE A WEEK OR NOT AT 
ALL? 
Almost every day .................................. 1 
At least once a week ............................. 2 
Less than once a week .......................... 3 
Not at all ............................................... 4 
 





MC11. DO YOU LISTEN TO THE RADIO 
ALMOST EVERY DAY, AT LEAST ONCE 
A WEEK, LESS THAN ONCE A WEEK OR 
NOT AT ALL? 
Almost every day .................................. 1 
At least once a week ............................. 2 
Less than once a week .......................... 3 
Not at all ............................................... 4 
 
MC12. WHICH RADIO STATION DO YOU LISTEN 
TO? 
  
MC13. HOW OFTEN DO YOU WATCH 
TELEVISION: WOULD YOU SAY THAT 
YOU WATCH ALMOST EVERY DAY, AT 
LEAST ONCE A WEEK, LESS THAN 
ONCE A WEEK OR NOT AT ALL? 
Almost every day .................................. 1 
At least once a week ............................. 2 
Less than once a week .......................... 3 





HOUSEHOLD CHARACTERISTICS  HC 










HC3. NUMBER OF CHILDREN  
UNDER AGE 5: 
_________  




Between R1000 and 
R5000……………...2 
Between R5000 and R10 
000……………3 




HC5. HOW FAR IS THE HOUSEHOLD FROM THE 

















HC7. USING THIS TRANSPORT HOW LONG DOES IT 
TAKE YOU FROM HOME TO THE CLINIC? 
Less than an hour………………..1 
1 hour…………………………2 
2 hours……………………………..3 




UNDER 5 CHILD INFORMATION UF 
UF1. ON WHAT DAY, MONTH AND 
YEAR WAS (NAME) BORN? 
Probe: 
 WHAT IS HIS / HER BIRTHDAY? 
If the mother/caretaker knows the exact 
birth date, also enter the day; otherwise, 
circle 98 for day. 
Month and year must be recorded. 
Date of birth 
 Day  __ 
 DK day ............................................... 8 
 Month .......................................... __ __ 




UF2.  HOW OLD IS (NAME)? 
PROBE:  
HOW OLD WAS (NAME) AT HIS / HER 
LAST BIRTHDAY? 
RECORD AGE IN COMPLETED YEARS. 
RECORD ‘0’ IF LESS THAN 1 YEAR. 
COMPARE AND CORRECT UF1 AND/OR 
UF2 IF INCONSISTENT. 
Age (in completed years) .................... __  
UF3. DOES (NAME) ATTEND ANY 
ORGANIZED LEARNING OR 
EARLY CHILDHOOD EDUCATION 
PROGRAMME, SUCH AS A 
PRIVATE OR GOVERNMENT 
FACILITY, INCLUDING CRÈCHE OR 
COMMUNITY CHILD CARE? 
Yes ......................................................... 1 
 
No .......................................................... 2 
 
DK ......................................................... 8 
 
UF4. WHAT IS THE NAME OF THIS FACILITY?   
UF5. HOW MANY HOURS PER DAY DOES 








VITAMIN A VA 
VA1.DO YOU HAVE A RTHB OR 
IMMUNIZATION CARD FOR 
(NAME) 
 If yes: MAY I SEE IT PLEASE? 
Yes, seen ................................................ 1 
Yes, not seen.......................................... 2 
No card .................................................. 3 
 
VA2. DATE OF VITAMIN A (FIRST 
DOSE) 
DATE OF VITAMIN A (SECOND 
DOSE) Check RTHB 
dd/month/year ____ / ____ / ____ (a) 
 
dd/month/year ____ / ____ / ____ (b) 
 
VA3. HAS (NAME) EVER RECEIVED A 
VITAMIN A CAPSULE (SUPPLEMENT) LIKE 
THIS ONE?   
- Show capsule or dispenser for 
different doses – 100,000 IU for 
those 6-11 months old, 200,000 IU 







VA4. HOW MANY MONTHS AGO DID (NAME) 
TAKE THE LAST DOSE? (CONFIRM BY 
CHECKING RTHB) 
Months ago (based on caregiver 
recall)......................................__ __ (a) 
Based on RTHB……………..__ __  (b) 
DK..........................................................3 
 
VA5. WHERE DID (NAME) GET THIS LAST 
DOSE? 
 
On routine visit to health facility ..........1  
Sick child visit to health facility ….2 
National Immunization Day 
campaign.........3   
Other (specify) ____________________ 
4 .......................................................5 
 
VA6. HAVE YOU EVER BEEN INFORMED BY A 





VA7. HOW OFTEN SHOULD CHILDREN 







VA8. AT WHAT AGE SHOULD CHILDREN 
RECEIVE THEIR FIRST DOSE OF VITAMIN A? 




VA9. WHAT IS THE VITAMIN A DOSAGE FOR 





VA10. WHAT IS THE VITAMIN A DOSAGE FOR 









VA11. DO YOU KNOW THE BENEFITS OF 
VITAMIN A? IF SO PLEASE LIST A FEW  
Eye health…………………………….1 
Immune system………………………2 
Reduce childhood illness………………3 
Do not know………………………..4 
Other (specify)……………………..5 
 
VA12. CAN YOU LIST AT LEAST 3 FOODS 



















EPI2. CHECK RTHB IF AND WHEN MEASLES 





EPI 3. WHAT WAS YOUR CHILD’S LAST 








ANNEXURE D: CONSENT FORM AND PARTICIPANT INFORMATION SHEET 
CONSENT FORM 
This Informed Consent Form is for caregivers of children participating in the research titled: Vitamin A 
Supplementation in children aged 12 to 59 months in Amajuba District: Investigating Low Coverage 
Name of Principle Investigator: Mbalenhle Luthando Mdlalose 
Name of Organization: University of KwaZulu Natal 
This Informed Consent Form has two parts: 
• Information Sheet (to share information about the study with you) 
• Certificate of Consent (for signatures if you agree to participate) 
You will be given a copy of the full Informed Consent Form 
PART II: Certificate of Consent 
Certificate of Consent  
I have been asked to give consent for my participation in this research study which will involve 
completing one questionnaire I have read the foregoing information, or it has been read to me. I have 
had the opportunity to ask questions about it and any questions that I have asked have been answered to 
my satisfaction.  I consent voluntarily to participate as a participant in this study. 
Print Name of Parent or Guardian __________________      
Signature of Parent of Guardian___________________ 
Date ___________________________ 
 Day/month/year    
If illiterate 
A literate witness must sign (if possible, this person should be selected by the participant and should 
have no connection to the research team). Participants who are illiterate should include their thumb 
print as well.   
I have witnessed the accurate reading of the consent form to the potential participant, and the individual 
has had the opportunity to ask questions. I confirm that the individual has given consent freely.  
Print name of witness_____________________             AND         Thumb print of participant 





                Day/month/year 
Statement by the researcher/person taking consent 
I have accurately read out the information sheet to the potential participant, and to the best of my 
ability made sure that the person understands that the following will be done: 
A questionnaire will be read out to the participant and researcher will record responses on behalf of the 
participant. 
I confirm that the participant was given an opportunity to ask questions about the study, and all 
the questions asked by him/her have been answered correctly and to the best of my ability. I confirm 
that the individual has not been coerced into giving consent, and the consent has been given freely and 
voluntarily.    
A copy of this Informed Consent Form has been provided to the participant ____ 




PARTICIPANT INFORMATION SHEET 
Part I: Information Sheet 
Introduction  
My name is Mbalenhle Luthando Mdlalose. I am a part-time student at the University of KwaZulu 
Natal and also I work for the Department of Health in Amajuba District. I am currently doing research 
on Vitamin A which is given to children by the Department of Health. Before doing any research it is 
important that we obtain your permission to take part in it. If there are any words or concepts that you 
do not understand, please stop me and these will be explained to you as we go along and you may ask 
questions at any time. 
Purpose 
This research is being conducted in order to find out how the program of Vitamin A is going in the 
district, how many children are receiving Vitamin A as well as to find possible reasons that some 
children do not receive Vitamin A. Results from this research may help to improve child health as it 
can help the department to find better ways of providing this service. 
Type of Research Intervention 
This research will be conducted through a structured questionnaire which will be filled in by the 
researcher while interviewing you. 
Selection of Participants  
You were selected because we want to talk to mothers or caregivers of children aged 12 to 59 months 
living in this area 
 Do you know why we are asking you to take part in this study? Do you know what the study is 
about? 
Voluntary Participation 
You do not have to agree to talk to us. You can choose to say no and any services that you and your 
family receive at health facilities will not change. You can ask as many questions as you like and we 
will take the time to answer them. You do not have to decide today. You can think about and tell me 
what you decide later. 
 If you decide not to take part in this research study, do you know what the options are? Do you 
know that you do not have to take part in this research study, if you do not wish so? Do you 




You will be participating in a questionnaire which will take place here in your household. The 
researcher will be reading out questions to you and recording your responses in the questionnaire. If 
there are questions which you do not want to answer we may skip them and move on to the next 
question. The answers recorded will be confidential and only the researcher will have access to them. 
The questionnaires will be destroyed after a year. 
Duration   
Completing of this questionnaire will take about 30 minutes of your time. 
 If you decide that you can take part in the study, do you know how much time will the 
questionnaire take? Where will it take place? If you agree to take part, do you know that you 
can stop participating? Do you know that you may not respond to the questions that you do not 
wish to respond to? Do you have any more questions? 
Risks and Discomforts 
Some questions may ask for information which is confidential or which you do not feel comfortable to 
answer. If you do not wish to answer a certain question that is fine and you do not have to provide an 
explanation as to why you do not wish to respond. 
Benefits  
There will be no direct and immediate benefit for participating in the research but your participation is 
likely to improve how health services are delivered for children in your community in the future. Your 
child will also be given Vitamin A if it is found that he/she is due for a dose. Please note that this is not 
dependent on your participation. 
Reimbursements  
You will not be provided with any payment for participating in this research. 
 Can you tell me if you have understood correctly the benefits of your participation in the 
research? Do you have any other questions? 
Confidentiality: 
Because something out of the ordinary is being done through research in your community it will draw 
attention. If you participate you may be asked questions by other members of the community. We will 
not be sharing personal information about you outside of the research team. The information that we 
collect from this research project will be kept confidential. Information about you will be put away and 
no-one but the researchers will be able to see it. Any information shared through reporting of this 
research will only have generalized information with no specific reference to you personally. 
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 Did you understand the procedures that we will be using to make sure that any information that 
we as researchers collect about your child will remain confidential? Do you have any more 
questions?  
Sharing of Research Findings 
At the end of the study, we will be sharing what we have learnt with the participants and with the 
community. Nothing that you tell us today will be shared with anybody outside the research team, and 
nothing will be attributed to you by name. A written report will be given to the participants which can 
be shared with their families. We will also publish the results in order that other interested people may 
learn from our research 
Right to refuse or withdraw 
You may choose not to participate in this study. Choosing to participate or not will not affect your 
treatment at any health facility in any way. You and your child will still have all the benefits that would 
otherwise be available at any health facility. You may stop participating in this research at any time you 
wish without losing any of your rights. 
Who to Contact 
If you have any questions you may ask them now or later, even after the study has started. If you wish 
to ask questions later, you may contact: [Mbalenhle Luthando Mdlalose, Cell: 0837520492, Email: 
mbaleeh@gmail.com]. This proposal has been reviewed and approved by BREC which is a committee 
whose task is to make sure that research participants are protected from harm. If you wish to find out 
more about BREC, please contact (……..) 
 Do you know that you do not have to take part in this study if you do not wish to? You can say 
No if you wish to? Do you know that you can ask me questions later, if you wish to? Do you 
know that I have given the contact details of the person who can give you more information 




ANNEXURE E: INSTRUCTIONS TO AUTHORS 
Preparing an article for anonymous review 
 To ensure a fair and unbiased review process, all submissions are to include an anonymised version of 
the manuscript. The exceptions to this are Correspondence, Book reviews and Obituary submissions. 
 Submitting a manuscript that needs additional blinding can slow down your review process, so please 
be sure to follow these simple guidelines as much as possible: 
An anonymous version should not contain any author, affiliation or particular institutional details that 
will enable identification. 
Please remove title page, acknowledgements, contact details, funding grants to a named person, and 
any running headers of author names. 
Mask self-citations by referring to your own work in third person. 
 General article format/layout 
Accepted manuscripts that are not in the correct format specified in these guidelines will be returned to 
the author(s) for correction, which will delay publication. 
 General: 
Manuscripts must be written in UK English. 
The manuscript must be in Microsoft Word or RTF document format. Text must be single-spaced, in 
12-point Times New Roman font, and contain no unnecessary formatting (such as text in boxes). 
Please make your article concise, even if it is below the word limit. 
Qualifications, full affiliation (department, school/faculty, institution, city, country) and contact details 
of ALL authors must be provided in the manuscript and in the online submission process. 
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Abbreviations should be spelt out when first used and thereafter used consistently, e.g. 'intravenous 
(IV)' or 'Department of Health (DoH)'. 
Scientific measurements must be expressed in SI units except: blood pressure (mmHg) and 
haemoglobin (g/dL). 
Litres is denoted with an uppercase L e.g. 'mL' for millilitres). 
Units should be preceded by a space (except for % and ºC), e.g. '40 kg' and '20 cm' but '50%' and 
'19ºC'. 
Please be sure to insert proper symbols e.g. µ not u for micro, a not a for alpha, b not B for beta, etc. 
Numbers should be written as grouped per thousand-units, i.e. 4 000, 22 160. 
Quotes should be placed in single quotation marks: i.e. The respondent stated: '...' 
Round brackets (parentheses) should be used, as opposed to square brackets, which are reserved for 
denoting concentrations or insertions in direct quotes. 
If you wish material to be in a box, simply indicate this in the text. You may use the table format –this 
is the only exception. Please DO NOT use fill, format lines and so on. 




Guideline word limit: 4 000 words 
 Research articles describe the background, methods, results and conclusions of an original research 
study. The article should contain the following sections: introduction, methods, results, discussion and 
conclusion, and should include a structured abstract (see below). The introduction should be concise – 
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no more than three paragraphs – on the background to the research question, and must include 
references to other relevant published studies that clearly lay out the rationale for conducting the study. 
Some common reasons for conducting a study are: to fill a gap in the literature, a logical extension of 
previous work, or to answer an important clinical question. If other papers related to the same study 
have been published previously, please make sure to refer to them specifically. Describe the study 
methods in as much detail as possible so that others would be able to replicate the study should they 
need to. Results should describe the study sample as well as the findings from the study itself, but all 
interpretation of findings must be kept in the discussion section, which should consider primary 
outcomes first before any secondary or tertiary findings or post-hoc analyses. The conclusion should 
briefly summarise the main message of the paper and provide recommendations for further study. 
Select figures and tables for your paper carefully and sparingly. Use only those figures that provided 
added value to the paper, over and above what is written in the text. 
Do not replicate data in tables and in text . 
 Structured abstract 
This should be 250-400 words, with the following recommended headings: 
Background: why the study is being done and how it relates to other published work. 
Objectives: what the study intends to find out 
Methods: must include study design, number of participants, description of the intervention, primary 
and secondary outcomes, any specific analyses that were done on the data. 
Results: first sentence must be brief population and sample description; outline the results according to 
the methods described. Primary outcomes must be described first, even if they are not the most 
significant findings of the study. 
Conclusion: must be supported by the data, include recommendations for further study/actions. 
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Please ensure that the structured abstract is complete, accurate and clear and has been approved by all 
authors. 
Do not include any references in the abstracts. 
Main article 
All articles are to include the following main sections: Introduction/Background, Methods, Results, 
Discussion, Conclusions. 
The following are additional heading or section options that may appear within these: 
Objectives (within Introduction/Background): a clear statement of the main aim of the study and the 
major hypothesis tested or research question posed 
Design (within Methods): including factors such as prospective, randomisation, blinding, placebo 
control, case control, crossover, criterion standards for diagnostic tests, etc. 
Setting (within Methods): level of care, e.g. primary, secondary, number of participating centres. 
Participants (instead of patients or subjects; within Methods): numbers entering and completing the 
study, sex, age and any other biological, behavioural, social or cultural factors (e.g. smoking status, 
socioeconomic group, educational attainment, co-existing disease indicators, etc)that may have an 
impact on the study results. Clearly define how participants were enrolled, and describe selection and 
exclusion criteria. 
Interventions (within Methods): what, how, when and for how long. Typically for randomised 
controlled trials, crossover trials, and before and after studies. 
Main outcome measures (within Methods): those as planned in the protocol, and those ultimately 
measured. Explain differences, if any. 
Results 
Start with description of the population and sample. Include key characteristics of comparison groups. 
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Main results with (for quantitative studies) 95% confidence intervals and, where appropriate, the exact 
level of statistical significance and the number need to treat/harm. Whenever possible, state absolute 
rather than relative risks. 
Do not replicate data in tables and in text. 
If presenting mean and standard deviations, specify this clearly. Our house style is to present this as 
follows: 
E.g.: The mean (SD) birth weight was 2 500 (1 210) g. Do not use the ± symbol for mean (SD). 
Leave interpretation to the Discussion section. The Results section should just report the findings as per 
the Methods section. 
Discussion 
Please ensure that the discussion is concise and follows this overall structure – sub-headings are not 
needed: 
Statement of principal findings 
Strengths and weaknesses of the study 
Contribution to the body of knowledge 
Strengths and weaknesses in relation to other studies 
The meaning of the study – e.g. what this study means to clinicians and policymakers 
Unanswered questions and recommendations for future research 
Conclusions 
This may be the only section readers look at, therefore write it carefully. Include primary conclusions 





The guest editor reviews the articles and returns them to the CME editor for review and final approval. 
rds about your current fields of interest. 
 
 
